Koligo Therapeutics (ASX:KOL) Total Receivables: A$0.00 Mil (As of . 20)


What is Koligo Therapeutics Total Receivables?

Koligo Therapeutics ASX:KOL Total Receivables is A$0.00 Mil as of . 20.

Koligo Therapeutics's Total Receivables for the quarter that ended in . 20 was A$0.00 Mil.

Koligo Therapeutics Total Receivables Related Terms

Koligo Therapeutics Total Receivables Historical Data

* Premium members only.

The historical data trend for Koligo Therapeutics's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Koligo Therapeutics Total Receivables Chart

Koligo Therapeutics Annual Data
Trend
Total Receivables

Koligo Therapeutics Semi-Annual Data
Total Receivables

Koligo Therapeutics Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of A$0.00 Mil mean?
Koligo Therapeutics (ASX:KOL) has a Total Receivables of A$0.00 Mil as of . 20. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Koligo Therapeutics and its competitors.
Is Koligo Therapeutics' Total Receivables too high?
Koligo Therapeutics' current Total Receivables is A$0.00 Mil.
How does Koligo Therapeutics' Total Receivables compare to ?
Koligo Therapeutics' Total Receivables of A$0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Biotechnology company?
A good Total Receivables depends on the Biotechnology industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Koligo Therapeutics and its competitors. Koligo Therapeutics's current Total Receivables is A$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Koligo Therapeutics stock overvalued right now?
Koligo Therapeutics (ASX:KOL) has a current Total Receivables of A$0.00 Mil. The current Total Receivables is A$0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For Koligo Therapeutics (ASX:KOL), the current Total Receivables is A$0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Koligo Therapeutics Business Description

Comparable Companies